In India, infertility is frequently seen as a social taboo, despite the fact that it is now curable owing to great developments in medical technology. One of the most crucial infertility therapies is surrogacy, however for a few decades now, commercialization of surrogacy has had an effect on India. Due to the fact that surrogacy is a relatively new notion in the country, there was neither formal legislation to govern it nor understanding that there should be one. The discussion is furthered by the fact that exploitative, unethical, and misinformed marketing was fostered by the fact that surrogacy was not even regarded as socially acceptable in the nation. India now has laws that outline the benefits of surrogacy and protect against its unethical promotion and dangers. The country's stereotypically gendered society, which stigmatizes infertility and views childlessness as unnatural, as well as the absence of infertility treatment in the public health system, can be blamed for India's huge privatized infertility care market's rise. The private infertility care sector makes money off of prevailing patriarchal normative cultural norms and attitudes. The proliferation of assisted reproductive technology is one of the most obvious examples of a reaction to market requirements, in this case, contemporary facilities enabling women to become mothers. The surrogacy market for ARTs in India has seen an increase in cross-border activity, demanding an investigation of the involvement of the major players as well as industry regulation.

#